The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-

Journal of Hepatology

Volumn 25, Issue 3, 1996, Pages 292-300

  Löhr, Hanns F ^a   Elste, Christina ^a   Dienes, Hans Peter ^a   Michel, Gerd ^b   Braun, Hans Bertram ^b   Meyer zum Büschenfelde, Karl Hermann ^a   Gerken, Guido ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Anti HCV antibody levels; HCV RNA levels; Hepatitis C; Immune complex formation; Interferon alpha; Therapy response monitoring

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNITY; IMMUNOASSAY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ISOLATION;

EID: 0030249520     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80114-0     Document Type: Article

References (41)

1. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamato H, Kamada T. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α Hepatology. 15:1992;37-41.
2. Shindo M, Di Bisceglie AM, Cheung L, Shih W.-K., Cristiano K, Feinstone SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Int Med. 115:1991;700-704.
3. Kurasaki M, Enomoto N, Sato C, Sakamoto N, Hoshino Y, Haritani H, Marumo F. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferases in non-A, non-B chronic liver disease. J Med Virol. 39:1993;246-250.
4. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, Purcell RH. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viraemia. J Infect Dis. 165:1992;1006-1011.
5. Houghton M, Weimer A, Kuo G, Choo Q.-L. Molecular biology of the hepatitis viruses: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
6. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
7. Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung M.-C., Scholz S, Nitschko H, Riethmüller G, Papae GR. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology. 21:1995;632-638.
8. Löhr HF, Schlaak JF, Kollmannsperger S, Meyer Zum Büschenfelde K.-H., Gerken G. Liver-infiltrating and peripheral blood T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver. 1996;. in press.
9. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M. Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci USA. 87:1990;6441-6444.
10. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology. 15:1992;351-353.
11. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327:1992;1490-1495.
12. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Wilson R. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 328:1993;465-470.
13. Douglas DD, Rakela J, Lin HJ, Hollinger FB, Taswell HF, Czaja AJ, Gross JB. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine-aminotransferase normalization vs. loss of HCV-RNA and anti-HCV IgM. Dig Dis Sci. 38:1993;601-607.
14. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, van Thiel DH, Amburro C, Lefkovitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A. The Hepatitis Interventional Group. Treatment of chronic hepatitis C with recombinant interferon-alpha. A multicenter randomized controlled trial. N Engl J Med. 321:1989;1501-1515.
15. DiBisceglie AM, Martin P, Kassianides C, Lisker-Melmann M, Murray I, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon-alpha therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med. 321:1989;1506-1510.
16. Manns M. Autoantibodies and antigens in liver disease - updated. J Hepatol. 9:1989;272-280.
17. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C an autoimmune chronic hepatitis: a comparative analysis. Hepatology. 15:1992;572-577.
18. Scheuer PJ. Classification of chronic viral hepatitis; aneed for reassessment. J Hepatol. 1991;372-374.
19. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for the detection of the hepatitis C virus. Lancet. 341:1993;722-724.
20. Gerken G, Pontisso P, Roggendorf M, Rumi MG, Simmonds P, Trepo C, Zeuzem S, Colucci G. Clinical evaluation of a single reaction diagnostic PCR assay for the detection of hepatitis C virus (HCV) RNA. J Hepatol. 24:1996;33-37.
21. Goergen B, Jakobs S, Meyer Zum Büschenfelde K.-H., Gerken G. Assessment of viral replication for routine diagnosis of HCV infection and for monitoring antiviral treatment using the AMPLICOR HCV detection system. Klin Lab. 40:1994;991-997.
22. Goergen B, Jakobs S, Meyer Zum Büschenfelde K.-H., Gerken G. Evaluation of different serum RNA extraction protocols using quantitative HCV-PCR. Hepatol. 21:1994;1157.
23. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kato M, Kondo M, Hayashi Y, Jonori T, Suzuki S. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Hepatology. 18:1993;1319-1325.
24. Simmonds P, McOmish F, Yap PL, Chan S.-W., Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 74:1993;661-668.
25. Stuyver L, Rossau R, Wyseur A, Dzuhamel LM, Vanderborght B, van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1105-1113.
26. Mimms L, Vallari D, Ducharme L, Holland P, Kuramato JK, Zeldis JB. Specificity of anti-HCV ELISA assessed by reactivity to three immunological HCV regions. Lancet. 336:1990;1590-1591.
27. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih J.W.-K. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol. 30:1992;552-556.
28. Theosilopoulos AN, Bokisch VA, Dixon FJ. Receptor for soluble C3 and C3b on human lymphoblastoid (Raji) cells. J Exp Med. 139:1974;696-709.
29. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Med Virol. 68:1994;1494-1500.
30. Farci P, Alter HJ, Govindarajan S, Wong D, Engle R, Lesniewski R, Mushawar I, Desai S, Miller R, Ogata N, Purcell RH. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
31. Chemello L, Cavalletto D, Pontisso P, Bortolotti F, Donada C, Donadon V, Frezza M, Casarin P, Alberti A. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology. 17:1993;179-182.
32. Brillanti S, Masci C, Ricci P, Migliogli M, Barbara L. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis. Hepatology. 15:1992;998-1001.
33. Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolome J, Carreno V. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis. Gastroenterology. 103:1992;1285-1289.
34. vitro in patients with chronic hepatitis C: correlation to disease activity and response to interferon-α Hepatology. 20:1994;1383-1389.
35. Löhr HF, Goergen B, Meyer Zum Büschenfelde K.-H., Gerken G. HCV replication in mononuclear cells reflects viral persistence and non-responsiveness to interferon-α J Med Virol. 46:1995;314-320.
36. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 42:1994;299-305.
37. Urushihara A, Sodeyama T, Matsumoto A, Tanaka E. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection. J Med Virol. 42:1994;348-356.
38. Yuki N, Hayashi AN, Kasahara A, Hagiwara H, Ohkawa K, Fusamato H, Kamada T. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins. Hepatology. 19:1994;1360-1365.
39. Peters M, Trippler M, Löhr HF, Gödderz W, Herr W, Störkel S, Meyer Zum Büschenfelde K.-H., Gerken G. Posttransfusional LKM-1 autoantibody-positive hepatitis C virus infection, cryoglobulinemia and aplastic anemia. Dig Dis Sci. 40:1995;763-773.
40. Durand JM, Kaplanski G, Lefevre P. Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis. 165:1992;778-779.
41. Marcellin P, Descamps V, Martinot-Peignoux M, Larzul D, Xu L, Boyer N, Pham B.-N., Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou J.-P. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology. 104:1993;272-277.